Very Short-Term Effects of Evolocumab in Patients Undergoing Percutaneous Coronary Angioplasty (PCI)
Not Applicable
Recruiting
- Conditions
- Ischemic Heart Disease
- Registration Number
- JPRN-UMIN000053575
- Lead Sponsor
- niversity of Fukui
- Brief Summary
T.B.D
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded patients with acute coronary syndrome, chronic total occlusion, patients who could not be followed with NIRS-IVUS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of biomarkier variability
- Secondary Outcome Measures
Name Time Method